PURPOSE: The human pathophysiology of stunned, hibernating and scarred myocardium in ischemic cardiomyopathy is a subject of controversy. While the "smart heart" theory postulates that reduced myocardial blood flow (MBF) at rest is responsible for myocytes switching to a state of hibernation, other theories suggest that a reduced myocardial flow reserve (MFR) may be the cause. METHODS: We included 110 patients with ischemic cardiomyopathy. Based on quantitative myocardial perfusion assessment and viability imaging with 13N-NH3 and 18F-FDG positron emission tomography, respectively, as well as wall motion assessment from echocardiography, myocardial tissue was characterized as remote (i.e., normal myocardium), stunned (i.e., dysfunctional but viable myocardium with normal rest perfusion), hibernating (i.e., dysfunctional but viable myocardium with impaired rest perfusion), or scarred myocardium (i.e., non-viable myocardium). RESULTS: Compared to remote myocardium, dysfunctional but viable myocardium (including stunned and hibernating) had reduced rest MBF (0.89 mL/min/g vs. 0.79 and 0.76 mL/min/g, respectively; p < 0.001) and MFR (1.53 vs. 1.27 and 1.17; p < 0.001). Between stunned and hibernating myocardium, however, rest MBF and MFR did not differ (p = 0.40). In scarred myocardium, rest MBF was lowest (0.66 mL/min/g; p < 0.001) but, in contrast to the other myocardial states, k2 (i.e., tracer washout) was increased (0.199/min vs. 0.178/min to 0.181/min; all p < 0.05 in pairwise comparison). CONCLUSIONS: In patients with ischemic cardiomyopathy, impaired MFR is associated with stunning and hibernation. These states of dysfunctional but viable myocardium have lower rest MBF compared to remote myocardium. At the end of the continuum, rest MBF is lowest in scar tissue and linked to increased rate of tracer washout.
PURPOSE: The human pathophysiology of stunned, hibernating and scarred myocardium in ischemic cardiomyopathy is a subject of controversy. While the "smart heart" theory postulates that reduced myocardial blood flow (MBF) at rest is responsible for myocytes switching to a state of hibernation, other theories suggest that a reduced myocardial flow reserve (MFR) may be the cause. METHODS: We included 110 patients with ischemic cardiomyopathy. Based on quantitative myocardial perfusion assessment and viability imaging with 13N-NH3 and 18F-FDG positron emission tomography, respectively, as well as wall motion assessment from echocardiography, myocardial tissue was characterized as remote (i.e., normal myocardium), stunned (i.e., dysfunctional but viable myocardium with normal rest perfusion), hibernating (i.e., dysfunctional but viable myocardium with impaired rest perfusion), or scarred myocardium (i.e., non-viable myocardium). RESULTS: Compared to remote myocardium, dysfunctional but viable myocardium (including stunned and hibernating) had reduced rest MBF (0.89 mL/min/g vs. 0.79 and 0.76 mL/min/g, respectively; p < 0.001) and MFR (1.53 vs. 1.27 and 1.17; p < 0.001). Between stunned and hibernating myocardium, however, rest MBF and MFR did not differ (p = 0.40). In scarred myocardium, rest MBF was lowest (0.66 mL/min/g; p < 0.001) but, in contrast to the other myocardial states, k2 (i.e., tracer washout) was increased (0.199/min vs. 0.178/min to 0.181/min; all p < 0.05 in pairwise comparison). CONCLUSIONS: In patients with ischemic cardiomyopathy, impaired MFR is associated with stunning and hibernation. These states of dysfunctional but viable myocardium have lower rest MBF compared to remote myocardium. At the end of the continuum, rest MBF is lowest in scar tissue and linked to increased rate of tracer washout.
Authors: Venkatesh L Murthy; Masanao Naya; Courtney R Foster; Jon Hainer; Mariya Gaber; Gilda Di Carli; Ron Blankstein; Sharmila Dorbala; Arkadiusz Sitek; Michael J Pencina; Marcelo F Di Carli Journal: Circulation Date: 2011-10-17 Impact factor: 29.690
Authors: P G Camici; W Wijns; M Borgers; R De Silva; R Ferrari; J Knuuti; A A Lammertsma; A J Liedtke; G Paternostro; S F Vatner Journal: Circulation Date: 1997-11-04 Impact factor: 29.690
Authors: Dominik A Steffen; Andreas A Giannopoulos; Marvin Grossmann; Michael Messerli; Moritz Schwyzer; Christoph Gräni; Cathérine Gebhard; Aju P Pazhenkottil; Philipp A Kaufmann; Ronny R Buechel Journal: J Nucl Cardiol Date: 2018-08-14 Impact factor: 5.952
Authors: Viviany R Taqueti; Rory Hachamovitch; Venkatesh L Murthy; Masanao Naya; Courtney R Foster; Jon Hainer; Sharmila Dorbala; Ron Blankstein; Marcelo F Di Carli Journal: Circulation Date: 2014-11-16 Impact factor: 29.690
Authors: Bernhard A Herzog; Lars Husmann; Ines Valenta; Oliver Gaemperli; Patrick T Siegrist; Fabian M Tay; Nina Burkhard; Christophe A Wyss; Philipp A Kaufmann Journal: J Am Coll Cardiol Date: 2009-07-07 Impact factor: 24.094
Authors: Catherine Gebhard; Michael Fiechter; Bernhard A Herzog; Christine Lohmann; Susan Bengs; Valerie Treyer; Michael Messerli; Dominik C Benz; Andreas A Giannopoulos; Christoph Gräni; Aju P Pazhenkottil; Ronny R Buechel; Philipp A Kaufmann Journal: Eur J Nucl Med Mol Imaging Date: 2018-05-19 Impact factor: 9.236
Authors: Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer Journal: Eur Heart J Date: 2016-05-20 Impact factor: 29.983
Authors: Mustafa Umut Somuncu; Fatih Pasa Tatar; Belma Kalayci; Ahmet Avci; Naile Eris Gudul; Begum Uygur; Ali Riza Demir; Murat Can Journal: Acta Cardiol Sin Date: 2021-09 Impact factor: 2.672
Authors: Sebastian Lehner; Isabel Nowak; Mathias Zacherl; Julia Brosch-Lenz; Maximilian Fischer; Harun Ilhan; Johannes Rübenthaler; Astrid Gosewisch; Peter Bartenstein; Andrei Todica Journal: J Nucl Cardiol Date: 2021-08-02 Impact factor: 3.872